Previous Close | 10.67 |
Open | 11.40 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 10.69 - 10.80 |
52 Week Range | 4.76 - 15.25 |
Volume | |
Avg. Volume | 172,650 |
Market Cap | 167.674M |
Beta (5Y Monthly) | -0.38 |
PE Ratio (TTM) | 9.99 |
EPS (TTM) | 1.07 |
Earnings Date | Aug 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 24, 2022 |
1y Target Est | 11.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for PRPH
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on Thursday, August 11, 2022 at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30,2022. A press release detailing these results will be issued prior to the call. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will host the conference call, followed b
ProPhase Labs, Inc. (PRPH) closed at $10.47 in the latest trading session, marking a -1.87% move from the prior day.
In this article, we discuss 10 stocks that are gaining after announcing share buybacks. If you want to see more stocks in this selection, click These 5 Stocks are Gaining After Announcing Share Buybacks. According to the Wall Street Journal, companies are intent on engaging in more repurchase activity in 2022 as compared to the […]